` CPH (Creso Pharma Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

CPH
vs
S
S&P/ASX 300

Over the past 12 months, CPH has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's +13% growth.

Stocks Performance
CPH vs S&P/ASX 300

Loading
CPH
S&P/ASX 300
Add Stock
www.alphaspread.com

Performance Gap
CPH vs S&P/ASX 300

Loading
CPH
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
CPH vs S&P/ASX 300

Loading
CPH
S&P/ASX 300
Add Stock

Competitors Performance
Creso Pharma Ltd vs Peers

S&P/ASX 300
CPH
LLY
JNJ
ROG
AZN
Add Stock

Creso Pharma Ltd
Glance View

Market Cap
17.7m AUD
Industry
Pharmaceuticals

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

CPH Intrinsic Value
Not Available
Back to Top